Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 181 of 181 entries
View as:

Phase 2 Study to Assess the Safety, PK, and PD in SBS-IF Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04775706 Org: User:
Start: 03/03/22 End: 05/31/28 Due: 05/31/29

Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102)

Phase: N/A Priority: Normal
NCT ID: NCT00986843 Org: User:
Start: 06/30/08 End: 09/30/12 Due: 09/30/13

Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04039724 Org: User:
Start: 02/28/15 End: 05/31/15 Due: 05/31/16

Evaluation the Effect of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT04346862 Org: User:
Start: 01/26/16 End: 06/30/20 Due: 06/30/21

HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)

Phase: N/A Priority: Normal
NCT ID: NCT04732416 Org: User:
Start: 05/05/22 End: 12/31/25 Due: 12/31/26

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules

Phase: N/A Priority: Normal
NCT ID: NCT02667938 Org: User:
Start: 03/31/15 End: 05/31/16 Due: 05/31/17